Ventrus Biosciences Balance Sheet - Quarterly (NASDAQ:ASMB)

Add to My Stocks
$58.17 $0.37 (0.63%) ASMB stock closing price Mar 20, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Ventrus Biosciences stock analysis. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Ventrus Biosciences stock analysis, and provides insights into the firm's financial performance. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Apart from analyzing Ventrus Biosciences revenue Ventrus Biosciences operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Ventrus Biosciences balance sheet for 2017 Q3 shows cash on hand of $27.24M. The company has a debt to equity ratio of .

View and download Ventrus Biosciences quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Marketable Securities39.05M36.12M20.1M24.38M34.85M43.2M37.92M40.55M29.39M
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets--1.29M------
Total Current Assets
Property Plant & Equipment---------
Accumulated Depreciation---------
Net Property Plant & Equipment
Investment & Advances1M3M-2.43M7.9M11.16M23.39M23.39M31.18M
Other Non-Current Assets---------
Deferred Charges---------
Deposits & Other Assets---------
Total Assets
Notes Payable---------
Accounts Payable--1.94M2.36M3.83M2.41M2.32M1.36M1.46M
Current Portion Long-Term Debt---------
Current Portion Capital Leases---------
Accrued Expenses6.35M6.3M4.01M4.75M3.64M2.63M1.24M2.03M1.18M
Income Taxes Payable---------
Other Current Liabilities4.99M4.99M4.99M------
Total Current Liabilities
Deferred Taxes/Income52.96M54.25M55.43M11.11M11.6M11.6M11.6M11.6M11.6M
Convertible Debt---------
Long-Term Debt---------
Non-Current Capital Leases---------
Other Long-Term Liabilities---------
Total Liabilities
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus295.53M292.67M290.55M288.68M287.54M286.48M284.97M283.51M281.99M
Retained Earnings-248.02M-235.75M-222.15M-208.22M-196.68M-185.1M-174.95M-163.96M-156.21M
Treasury Stock---------
Other Liabilities-0.38M-0.39M-0.52M-0.6M-0.83M-0.83M-0.74M-0.82M-0.38M
Shareholders Equity47.13M56.53M67.88M79.87M90.04M100.56M109.28M118.74M125.4M
Total Liabilities & Shareholders Equity112.31M122.77M134.28M98.11M109.12M117.2M124.45M133.74M139.65M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the Ventrus Biosciences stock price by looking at Ventrus Biosciences historical stock prices. One can compare PE with industry average by looking at the Ventrus Biosciences PE ratio chart. The common balance sheet items are:

  • Assets: Anything that the Ventrus Biosciences company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Ventrus Biosciences had total assets of $112.31M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. ASMB stock had total liabilities of $65.18M for the quarter 2017 Q3.

Ventrus Biosciences Balance Sheet - Key Ratios

Price to book ratio